Case Presentation from Vascular Division
David B. Zora, MD, Matthew Gao, MD
Published July 9, 2024 | Clinics in Medical Education
Issue 1 | Volume 1 | July 2024
Patient is a 73yo female with hx of HTN, DM, CKD III (Cr 1.8), pericardial effusion and MI in 2017, hx portal vein thrombosis in the setting of diverticulitis (Rx with coumadin for 6 months, NOT on anticoagulation now). Prior history of smoking 50 years. Stress test negative. She’s getting an open resection for infrarenal thrombi-filled AAA.

On Physical examination: 60 inches, 50 kg weight. BP 150/78 mm of Hg, RR 14/minute, Pulse 90/minute. Important labs: BUN/Cr 30/1.8, Hct 27, BNP 300pg/l, Chest Xray normal lung and cardiac silhouette.
Perioperative management: Preop: 1. Large IVs 2. A-line 3. Epidural INR 1.5 what other options for multimodal analgesia? For example, rectus sheath block, TAP block, ketamine
Intraoperative:
- GA with maintaining hemodynamic stability
- Central line for CVP monitoring
- Non-invasive monitoring LIDCO for SVV, CO and SVR
- TEE or TTE depends on the expertise
- Nitroglycerine and phenylephrine on the pump
- Consider renal protection strategies
Management:
- Goal directed fluid management is the protocolized use of cardiac output and related parameters as end points for fluid and/or inotropic therapy administration.
- Goal directed coagulation management (TEG, ACT, platelets, INR when needed)
- Goal directed resuscitation (baseline blood gas and afterwards every hour or half an hour depending on the stage of surgery, SVV, end systolic and end diastolic diameter, PPV for fluid management.)
- Starting from clamping the aorta, goal directed volume with blood, balanced crystalloids (plasmalyte), and albumin. Consider FFP, platelet depending on the amount and time period of blood loss.
- Will you consider Cell Saver?
- Anticipate hemodynamic changes with cross clamping and release of cross clamping (aggressive preload and tone support).
- Frequent labs for acidosis and ischemia reperfusion injury evaluation.
- Appropriate temperature management and avoid hypothermia and at the same time hyperthermia to the legs during cross clamp.
Reasons when to consider Cell Saver
- When anticipated blood loss is >1 L or 20% of the patient’s estimated blood volume (EBV).
- In patients with a low hemoglobin concentration or who are at increased risk of bleeding.
- In patients with multiple antibodies or rare blood types (cross-match compatible blood is unobtainable).
- In patients who are unwilling to accept allogeneic blood (e.g. Jehovah’s Witnesses).
Cell saver is the process of collecting blood from the operative field, which is then anticoagulated, centrifuged, filtered, washed and finally re-suspended in saline. Coagulation factors and platelets are entirely removed by the cell saver. Salvaged red cells can then be transfused to the patient during or after the surgery as required (within 6 h). According to a recent Cochrane review, cell saver is associated with a 38% reduction of allogeneic blood transfusion, without significant safety concerns being raised.
End of surgery: Surgery finished uneventfully, you gave 650 cc from the cell saver, 2 packed RBC, three liters of plasmalyte. Total EBL 1.8 liters. Urine output 200 cc. PPV 8, CO 4.0 l/minute. End diastolic diameter is 11cm. Blood gas Lactate is 1.5 to 5.5 soon after the infrarenal clamp. Base deficit is -2, Hct 28. The incision site looks dry. You are asked to give protamine. Fixed protamine dose regimen-1-1.3mg of protamine for each100IU of heparin. For this patient 30 mg of protamine is given slowly after test dose. Suddenly, patient became hypotensive with systolic pressure in 50/30 mm of Hg.
What is the differential diagnosis?
Treatment options:
In order to improve RV function, we need to
1. Reduce RV volume and pressure
- Normalizes Septal Position
- Maintaining shape/geometry
- Improves right ventricular function
2. Increasing systemic pressure
- Normalizes septal position
- Improves right ventricular perfusion
3. Lower PVR improves forward flow
4. Maintain Heart Rate (80-100 bts/min)
5. Inotropic support to improve ventricular function and septal contribution
- Epinephrine, Norepinephrine, Milrinone, Vasopressin, Nitric oxide, Iloprost.
6. Patient-Optimization
- Avoid hypoxia
- Avoid hypercapnia
- Avoid Acidosis
- Ionotropic support
- Avoid hypotension
Patient became stable hemodynamically on epinephrine gtt and nitric oxide. Patient was transported to the ICU intubated.
REFERENCES
1. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA. Cell salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010
2. Tamura T, Waters JH, Nishiwaki K. Heparin. Concentration in cell salvage during heparinization: a pilot study. Nagoya J Med Sci. 2020